Free Trial
NASDAQ:RNTX

Rein Therapeutics (RNTX) Stock Price, News & Analysis

$1.70 +0.00 (+0.01%)
As of 03:21 PM Eastern

About Rein Therapeutics Stock (NASDAQ:RNTX)

Key Stats

Today's Range
$1.55
$1.81
50-Day Range
N/A
52-Week Range
$1.50
$7.42
Volume
31,734 shs
Average Volume
58,674 shs
Market Capitalization
$36.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. It has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts.

Remove Ads
Receive RNTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rein Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RNTX Stock News Headlines

Rein Therapeutics Inc. (RNTX)
See More Headlines

RNTX Stock Analysis - Frequently Asked Questions

Rein Therapeutics' stock was trading at $2.05 at the start of the year. Since then, RNTX stock has decreased by 19.3% and is now trading at $1.6550.
View the best growth stocks for 2025 here
.

Shares of RNTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RNTX
Web
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-15,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.41 per share
Price / Book
1.13

Miscellaneous

Free Float
20,561,000
Market Cap
$34.67 million
Optionable
N/A
Beta
2.12
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:RNTX) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners